Yamagishi, Sho-ichi <br/><br/>
Olmesartan blocks advanced glycation end products (AGEs)-induced angiogenesis in vitro by suppressing receptor for AGEs (RAGE) expression.  [electronic resource] 

 -  Microvascular research  Jan 2008 
 - 130-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0026-2862 
<br/><br/><label>Standard No.: </label>10.1016/j.mvr.2007.05.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Angiotensin II Type 1 Receptor Blockers--pharmacology<br/>Cells, Cultured<br/>DNA Replication--drug effects<br/>Diabetic Retinopathy--metabolism<br/>Down-Regulation<br/>Endothelial Cells--drug effects<br/>Glycation End Products, Advanced--metabolism<br/>Humans<br/>Imidazoles--pharmacology<br/>NF-kappa B--genetics<br/>Neovascularization, Pathologic--genetics<br/>Promoter Regions, Genetic<br/>RNA, Messenger--metabolism<br/>Receptor for Advanced Glycation End Products<br/>Receptors, Immunologic--genetics<br/>Research Design<br/>Tetrazoles--pharmacology<br/>Transfection<br/>Vascular Endothelial Growth Factor A--genetics